Feedback / Questions
AIC100 - AffyImmune Therap
https://www.businesswire.com/news/home/20240408382880/en/AffyImmune-Therapeutics-Announces-Clinical-and-Regulatory-Advisory-Board-to-Support-Development-of-AIC100-in-Solid-Tumors
Apr 8, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next